Temple Health leads research showing how women and non-smokers face rising risks, and how new treatments are changing the ...

Quit smoking and control your indoor air quality. Exposure to smoke, dust, fumes, vapors and chemicals can worsen your COPD.

Cash and Cash Equivalents: As of September 30, 2025, Kymera had $978.7 million in cash, cash equivalents and investments. Kymera expects that its cash balance will provide the Company with a cash ...

Ambetter from WellCare of Kentucky, a product offered by a Centene Corporation (NYSE: CNC) company, a leading healthcare ...

I have a 72-year-old friend who is declining with chronic obstructive pulmonary disease (COPD). She got divorced 4 years ago. She has a 32-year-old son. Does she need a will? She has not written a new ...

"She has not written a new will since the divorce." (Photo subject is a model.) I have a 72-year-old friend who is declining with chronic obstructive pulmonary disease (COPD). She got divorced 4 years ...

A: First, let’s define medicine: Merriam Webster says it’s a substance or preparation used to treat disease and Britannica ...

AstraZeneca's hopes of a big new indication for respiratory drug Fasenra in chronic obstructive pulmonary disease (COPD) have been dashed by a negative phase 3 trial. The RESOLUTE study of IL-5 ...

The FDA has approved an update to the prescribing information for Merck‘s PAH treatment Winrevair (sotatercept-csrk).

Operator: Good morning, and welcome to the Liquidia Corporation Third Quarter 2025 Financial Results and Corporate Update ...

Recorded $51.7 million in net product sales of YUTREPIA™ as launch momentum continuesAchieved profitability in the first full quarter of YUTREPIA ...

The FDA has expanded the approval of Winrevair to include treatment of adults with PAH WHO Group 1 to improve exercise capacity and WHO FC, and reduce the risk of clinical worsening events including ...